Equity Research, Broker Reports, and media content on Advanced Oncotherapy

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Advanced Oncotherapy
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Advanced Oncotherapy. We currently have 91 research reports from 5 professional analysts.

Open
38.5p
Range Today
38.5/39.2p
52 Week
33.0/52.0p
Daily Volume
7.6k
# Shares
230.2m
Daily Liquidity
(0.00%)
Pension Liability
£0m
Enterprise Value
£87.0m
Market Cap
£88.6m
Latest PE (hist)
Div Yield
Date Source Announcement
09Sep19 16:48 RNS Exercise of Warrants and Issue of Equity
30Aug19 17:00 RNS Total Voting Rights
29Aug19 14:06 RNS Holding(s) in Company
27Aug19 07:00 RNS Total Voting Rights and Directors' Shareholdings
08Aug19 10:45 EQS Hardman & Co Research: Advanced Oncotherapy (AVO): Nearing the end-goal
07Aug19 07:00 RNS Issue of equity and new debt facility
06Aug19 11:05 RNS Second Price Monitoring Extn
  • Frequency of research reports

     

  • Research reports on

    Advanced Oncotherapy

  • Providers covering

    Advanced Oncotherapy